Jump to main content
Jump to site search

Issue 3, 2014
Previous Article Next Article

Protein microarray technology: how far off is routine diagnostics?

Author affiliations

Abstract

The nature of protein microarray platforms is favorable for multiplexing, leading to the development of tools for personalised medicine and highly precise diagnostics. However, to date, only a limited number of protein microarrays are available in the in vitro diagnostics (IVD) market. This review article will focus on the following operational challenges that are crucial for the use of microarrays in clinical settings: (1) probe printing and quality control; (2) procurement of bio-reagents and antibody cross-reactivity; (3) mass transport limitations and assay automation; (4) calibration and quantification. A selection of microarray assays applicable to IVD and a summary of the diagnostic products currently available on the market are provided.

Graphical abstract: Protein microarray technology: how far off is routine diagnostics?

Back to tab navigation

Publication details

The article was received on 28 Aug 2013, accepted on 13 Nov 2013 and first published on 11 Dec 2013


Article type: Critical Review
DOI: 10.1039/C3AN01619F
Citation: Analyst, 2014,139, 528-542
  •   Request permissions

    Protein microarray technology: how far off is routine diagnostics?

    M. Cretich, F. Damin and M. Chiari, Analyst, 2014, 139, 528
    DOI: 10.1039/C3AN01619F

Search articles by author

Spotlight

Advertisements